InvestorsHub Logo
Followers 43
Posts 899
Boards Moderated 0
Alias Born 05/12/2001

Re: None

Thursday, 07/01/2021 9:02:56 AM

Thursday, July 01, 2021 9:02:56 AM

Post# of 164
23andMe rises after Richard Branson SPAC merger

- 23andMe, the genetic testing company that pioneered the business of personalized gene testing kits, traded higher in its public market debut under the ticker symbol “ME” on Thursday after a merger with a Richard Branson SPAC.
- 23andMe founder and CEO Anne Wojcicki told CNBC the company is planning to build a big consumer business off its base of 11 million customers and drug research and development platform with near-80% of test takers opting into sharing their genetic information for disease R&D.
- It is a five-time CNBC Disruptor 50 company.

https://www.cnbc.com/2021/06/17/gene-testing-firm-23andme-trades-higher-after-branson-spac-merger-.html
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ME News